Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

被引:51
作者
Ponsioen, Cyriel Y. [1 ]
Lindor, Keith D. [2 ]
Mehta, Ruby [3 ]
Dimick-Santos, Lara [3 ]
机构
[1] Acad Med Ctr, Dept Gastroenterol Hepatol, POB 22700, NL-1100 DE Amsterdam, Netherlands
[2] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA
[3] US FDA, Div Gastroenterol & Inborn Errors Prod, Silver Spring, MD USA
关键词
DOSE URSODEOXYCHOLIC ACID; PRIMARY BILIARY-CIRRHOSIS; HISTOLOGIC SCORING SYSTEMS; NATURAL-HISTORY; ALKALINE-PHOSPHATASE; TRANSIENT ELASTOGRAPHY; PROGNOSTIC VALUE; ULCERATIVE-COLITIS; GRADING SYSTEM; LIVER-FUNCTION;
D O I
10.1002/hep.29882
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary sclerosing cholangitis (PSC) is a rare and chronic liver disease for which there is no effective therapy. Interest has grown in developing treatments for this condition, with several agents proposed as potential therapies. However, there is a lack of clarity about how to measure clinical benefit in trials involving patients with this complex and rare disease. This article reviews regulatory information, the available literature on natural history, as well as potential candidate clinical and surrogate endpoints for PSC. (Hepatology 2018; 00:000-000).
引用
收藏
页码:1174 / 1188
页数:15
相关论文
共 78 条
[41]   Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management [J].
Ilyas, Sumera I. ;
Eaton, John E. ;
Gores, Gregory J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (12) :2152-2165
[42]   Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems [J].
Kakuda, Yuko ;
Harada, Kenichi ;
Sawada-Kitamura, Seiko ;
Ikeda, Hiroko ;
Sato, Yasunori ;
Sasaki, Motoko ;
Okafuji, Hirofumi ;
Mizukoshi, Eishiro ;
Terasaki, Shuichi ;
Ohta, Hajime ;
Kasashima, Satomi ;
Kawashima, Atsuhiro ;
Kaizaki, Yasuharu ;
Kaneko, Shuichi ;
Nakanuma, Yasuni .
HUMAN PATHOLOGY, 2013, 44 (06) :1107-1117
[43]   The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis [J].
Levy, C ;
Lymp, J ;
Angulo, P ;
Gores, GJ ;
Larusso, N ;
Lindor, KD .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (09) :1734-1740
[44]   Evaluating Co-primary Endpoints Collectively in Clinical Trials [J].
Li, Qian H. .
BIOMETRICAL JOURNAL, 2009, 51 (01) :137-145
[45]   Ursodiol for primary sclerosing cholangitis [J].
Lindor, KD .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (10) :691-695
[46]   High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis [J].
Lindor, Keith D. ;
Kowdley, Kris V. ;
Luketic, Velimir A. C. ;
Harrison, M. Edwyn ;
McCashland, Timothy ;
Befeler, Alex S. ;
Harnois, Denise ;
Jorgensen, Roberta ;
Petz, Jan ;
Keach, Jill ;
Mooney, Jody ;
Sargeant, Carol ;
Bernard, Tamara ;
King, Debra ;
Miceli, Ellen ;
Schmoll, Jeff ;
Hoskin, Tanya ;
Thapa, Prabin ;
Enders, Felicity .
HEPATOLOGY, 2009, 50 (03) :808-814
[47]   Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis [J].
Lindstrom, Lina ;
Hultcrantz, Rolf ;
Boberg, Kirsten Muri ;
Friis-Liby, Ingalill ;
Bergquist, Annika .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (07) :841-846
[48]   Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? [J].
Marelli, Laura ;
Xirouchakis, Elias ;
Kalambokis, Georgios ;
Cholongitas, Evangelos ;
Hamilton, Mark I. ;
Burroughs, Andrew K. .
GUT, 2011, 60 (09) :1224-1228
[49]   Extrahepatic Cholestasis Increases Liver Stiffness (FibroScan) Irrespective of Fibrosis [J].
Millonig, Gunda ;
Reimann, Frank A. ;
Friedrich, Stephanie ;
Fonouni, Hamidreza ;
Mehrabi, Arianeb ;
Buechler, Markus W. ;
Seitz, Helmut Karl ;
Mueller, Sebastian .
HEPATOLOGY, 2008, 48 (05) :1718-1723
[50]   A Retrospective Single-Center Review of Primary Sclerosing Cholangitis in Children [J].
Miloh, Tamir ;
Arnon, Ronen ;
Shneider, Benjamin ;
Suchy, Frederick ;
Kerkar, Nanda .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (02) :239-245